Ensysce Biosciences Inc (ENSC) stock news · P/E 0.0, rev $5.1M
Ensysce Biosciences Inc (ENSC) is a biotechnology company listed on US.
This ENSC news page leads with what Ensysce Biosciences Inc filed — not a scraped headline mill.
No cached 8-K sentence for ENSC yet. We will not pad this page with generic market recap.
Latest reported ENSC revenue for 2025-12-31 was $5.1M. Net income was -$10.2M. Revenue was down 2.8% from 2024-12-31 to 2025-12-31. ENSC currently screens at market cap $5.2M and trailing P/E 0.0.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ENSC stock page; for the tape open the quote page.
Not investment advice.